Astra Zeneca will commence a new study called EUCLID of Brilinta/Brilique(ticagrelor) to compare twice daily dosing of Brilinta/Brilique with once...
On 21 March 2013, the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal...
VANISH-2, the first of two US Phase III studies comparing Varisolve (polidocanol endovenous microfilm) from BTG with placebo in patients...
The 125 patient ORION trial of the Epic self-expanding nitinol stent system for Iliac Artery Disease from Boston Scientific, met...
Ventrus Biosciences, Inc. has reported that its Phase III, randomized, double-blind, placebo-controlled clinical trial of iferanserin (VEN 309) in patients...
oston Scientific announced FDA approval and market launch of the Epic Vascular Self-Expanding Stent System. The Epic Stent is designed...
The FDA has given 510(K) clearance to market the Chocolate PTA balloon catheter, from TriReme Medical, for the treatment of...
Ventrus Biosciences Inc. expects to report in June 2012 the results of a pivotal Phase III trial of inferanserin (VEN...
Six-month results from the BIOLUX P-I study, demonstrating excellent safety and efficacy results for the Biotronik Passeo-18 Lux Paclitaxel Releasing...
Abbott initiates ABSORB BTK, an international clinical trial evaluating the safety and efficacy of the Absorb bioresorbable vascular scaffold for...